CHASERR: The Potential Drug Target and Biomarker (G100507217)

Target Name: CHASERR

NCBI ID: G100507217

CHASERR

Other Name(s): CHASERR variant 1 | CHD2 adjacent suppressive regulatory RNA | CHD2 adjacent suppressive regulatory RNA, transcript variant 1 | LINC01578

CHASERR: The Potential Drug Target and Biomarker

CHASERR is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. Its full name is chronic homophilic interaction-mediated avoidance learning and regression (CHIMAR), and it is involved in the regulation of avoidance behaviors.

CHASERR is a member of the superfamily of G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are composed of four transmembrane subunits that include an extracellular portion, a transmembrane segment, an intracellular segment, and an intranuclein segment. The intracellular segment includes the catalytic center, which is responsible for the binding of ligands, and the cytoplasmic region, which includes the hormone-binding sites.

CHASERR is a 21-kDa protein that is expressed in the brain and other tissues of the body. It is highly conserved, with a calculated pI of 4.8 nM and a predicted localization in the brain. CHASERR is involved in the regulation of avoidance behaviors, which are behaviors that are performed in response to threats, such as escape from enclosed spaces or avoidance of noxious stimuli.

CHASERR is involved in the regulation of avoidance behaviors by modulating the activity of other GPCRs, particularly the GPCR known as TRPV1. TRPV1 is a GPCR that is expressed in various tissues of the body and is involved in the regulation of pain, temperature, and inflammation. CHASERR has been shown to interact with TRPV1 and to modulate its activity.

CHASERR is also involved in the regulation of avoidance behaviors by modulating the activity of the GPCR known as GABA伪. GABA伪 is a GPCR that is involved in the regulation of anxiety, stress, and other physiological processes. CHASERR has been shown to interact with GABA伪 and to modulate its activity.

CHASERR is a potential drug target for the treatment of various psychiatric and neurological disorders, including anxiety, depression, and PTSD. By modulating the activity of TRPV1 and GABA伪, CHASERR may be involved in the regulation of pain, temperature, and anxiety, which are potential targets for therapeutic intervention.

In addition to its potential therapeutic applications, CHASERR is also a potential biomarker for the diagnosis of various psychiatric and neurological disorders. The regulation of avoidance behaviors is a key aspect of these disorders, and changes in CHASERR levels may provide insight into the severity and progression of these disorders.

Overall, CHASERR is a protein that is involved in the regulation of avoidance behaviors and has potential as a drug target and biomarker for the treatment of psychiatric and neurological disorders. Further research is needed to fully understand its role in these processes and to develop effective therapeutic interventions.

Protein Name: CHD2 Adjacent Suppressive Regulatory RNA

The "CHASERR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHASERR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets